HomeCompareRDWU vs MRK

RDWU vs MRK: Dividend Comparison 2026

RDWU yields 23.45% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RDWU wins by $33.2K in total portfolio value
10 years
RDWU
RDWU
● Live price
23.45%
Share price
$8.53
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$90.0K
Annual income
$9,585.62
Full RDWU calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RDWU vs MRK

📍 RDWU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRDWUMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RDWU + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RDWU pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RDWU
Annual income on $10K today (after 15% tax)
$1,992.97/yr
After 10yr DRIP, annual income (after tax)
$8,147.78/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $180.63/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RDWU + MRK for your $10,000?

RDWU: 50%MRK: 50%
100% MRK50/50100% RDWU
Portfolio after 10yr
$73.4K
Annual income
$9,691.88/yr
Blended yield
13.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RDWU
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RDWU buys
0
MRK buys
0
No recent congressional trades found for RDWU or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRDWUMRK
Forward yield23.45%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$90.0K$56.8K
Annual income after 10y$9,585.62$9,798.13
Total dividends collected$55.3K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RDWU vs MRK ($10,000, DRIP)

YearRDWU PortfolioRDWU Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,045$2,344.67$11,206$366.19+$1.8KRDWU
2$16,816$2,858.45$12,650$502.35+$4.2KRDWU
3$21,437$3,443.83$14,407$694.19+$7.0KRDWU
4$27,041$4,102.97$16,585$967.82+$10.5KRDWU
5$33,771$4,836.88$19,342$1,363.89+$14.4KRDWU
6$41,780$5,645.47$22,913$1,947.19+$18.9KRDWU
7$51,232$6,527.48$27,662$2,823.89+$23.6KRDWU
8$62,299$7,480.59$34,159$4,173.35+$28.1KRDWU
9$75,161$8,501.40$43,337$6,308.80+$31.8KRDWU
10$90,008$9,585.62$56,776$9,798.13+$33.2KRDWU

RDWU vs MRK: Complete Analysis 2026

RDWUStock

RDWU uses swap agreements and listed call options to make bullish bets on the share price of Redwire Corporation (NYSE: RDW). The fund may also invest directly in the RDW. Redwire Corporation provides critical space solutions and space infrastructure for the next-generation space economy. It serves government and commercial customers worldwide. It holds IP in solar power generation and in-space 3D printing and manufacturing. It helps its customers address the challenges of future space missions. The fund seeks to maintain daily leveraged exposure equivalent to 200% of the daily percentage change in RDW price through daily rebalancing. Returns may deviate from the expected 200% if held for longer than a single day due to factors such as volatility and compounding. The fund expects to invest in US Government securities, money market funds, short-term bond ETFs, and corporate debt as collateral.

Full RDWU Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RDWU vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RDWU vs SCHDRDWU vs JEPIRDWU vs ORDWU vs KORDWU vs MAINRDWU vs JNJRDWU vs ABBVRDWU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.